Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Abdominal Cancer: early-phase trial registry

2 of 8 indexed Abdominal Cancer trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

8 US clinical trials · 2 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Abdominal Cancer: 8 US clinical trials tracked, 2 recruiting.

Abdominal Cancer is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Patrick Wagner, MD, FACS, running 2 of these trials.

Enrollment posture brief

Registry condition abdominal-cancer

OPEN 2 | RECR 25% | LATE 0 | EARLY 2 | RANK #2176 | SPON 2

Nearest open-share peer: Abdominal Pain (25% recruiting · 20 trials)

Activity, Motor75%Achalasia50%Acute-graft-versus-host Dise37.5%Acne Scars - Mixed Atrophic 25%Abdominal Cancer (this)25%
Open-enrollment share among volume-matched conditions near Abdominal Cancer

Abdominal Cancer lists 2 open slots (25% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Abdominal Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Abdominal Cancer is recruiting below its size-band peers.

    2 of 8 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Abdominal Cancer research.

    Patrick Wagner, MD, FACS accounts for 2 of 8 trials (25%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Most Abdominal Cancer trials plan to enrol fewer than 100 people.

    Median target enrolment is 65 among the 8 trials that report a genuine target (sentinel values excluded). 6 of those (75%) plan for fewer than 100 participants.

  4. Abdominal Cancer research is mostly interventional.

    6 interventional and 2 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1

Named interventions

Most-linked intervention names on Abdominal Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Motion CT Scans Procedure
1 trials
Tidal volume measured by spirometer and DIBH surface from CT image Device
1 trials
Lipopolysaccharide Biological
1 trials
NSS-2 Bridge Device
1 trials
HyperSight imaging Device
1 trials
Reirradiation Radiation
1 trials
Cardiopulmonary Exercise Testing (CPET) Other
1 trials
Sham NSS-2 BRIDGE Device
1 trials

US sites by state

Facility locations filed on Abdominal Cancer trials. A trial with sites in several states counts in each.

Texas 3 trials
Pennsylvania 3 trials
Ohio 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Abdominal Cancer page

8 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Abdominal Cancer condition card totals 8 registered trials; most-linked intervention Motion CT Scans; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.